Abstract:BACKGROUND: Perinatal hypoxia triggers the release of cytokines and chemokines by neurons, astrocytes and microglia. In response to hypoxia-ischemia resting/ramified microglia proliferate and undergo activation, producing proinflammatory molecules. The brain damage extension seems to be related to both the severity of hypoxia and the balance between pro and anti-inflammatory response and can be explored with neuroimaging.AIMS: The aim of this preliminary study was to explore possible relationships between plasma levels of inflammatory cytokines/chemokines and the severe brain damage detectable by Magnetic Resonance Imaging (MRI), performed during the hospitalization.METHODS: In 10 full terms neonates with hypoxic ischemic encephalopathy (HIE) undergoing therapeutic hypothermia (TH), divided into cases and controls, according to MRI results, we measured and compared the plasma levels of CCL2/MCP-1, CXCL8, GFAP, IFN y, IL-10, IL-18, IL-6, CCL3, ENOLASE2, GM-CSF, IL-1b, IL-12p70, IL-33, TNFα, collected at four different time points during TH (24, 25-48, 49-72 h of life, and 7-10 days from birth). Five of enrolled babies had pathological brain MRI (cases) and 5 had a normal MRI examination (controls). Cytokines were measured by Magnetic Luminex Assay. MRI images were classified according to Barkovich's score.RESULTS: Mean levels of all cytokines and molecules at time T1 were not significantly different in the two groups. Comparing samples paired by day of collection, the greatest differences between cases and controls were found at times T2 and T3, during TH. At T4, levels tended to get closer again (except for IL-6, IL10 and IL18). Infants with worse MRI showed higher plasmatic GFAP levels than those with normal MRI, while their IL-18 was lower. The mean levels of CCL3MIP1alpha, GMCSF, IL1BETA overlapped throughout the observation period in both groups.CONCLUSION: In a small number of infants with worse brain MRI, we found higher levels of GFAP and of IL-10 at T4 and a trend toward low IL-18 levels than in infants with normal MRI, considered early biomarker of brain damage and a predictor of adverse outcome, respectively. The greatest, although not significant, difference between the levels of molecules was found in cases and controls at time points T2 and T3, during TH.

IMPAIRED CELLULAR IMMUNITY IN NEONATE WITH HYPOXIC-ISCHEMIC ENCEPHALOPATHY(HIE)

Study on the Changes of Cytokines in Neonates with Hypoxic Ischemic Encephalopathy

Study on Immune Function Status in Normal and Asphyxiated Neonates.

CHANGES OF THE CONCENTRATIONS OF SERUM IL-8,IL-10 AND NSE IN NEONATES WITH HYPOXIC-ISCHEMIC ENCEPHALOPATHY AND THEIR CLINICAL SIGNIFICANCE

Umbilical Artery Blood S100β Protein: a Tool for the Early Identification of Neonatal Hypoxic-Ischemic Encephalopathy

Research Progress of Relationship Between Hyptoxic Ischemic Encephalopathy and Interleukin in Neonates

Changes and Significances of Serum Levels of Macrophage Migration Inhibitory Factor and Matrix Metalloproteinase-9 in Newborn Infants with Hypoxic-Ischemic Encephalopathy

Clinical significance of level variation of serum adiponectin and insulin-like growth factor-1 in neonates with hypoxic-ischemic encephalopathy

Effects of Hypothermia on Nse and S-100 Protein Levels in Csf in Neonates Following Hypoxic/Ischaemic Brain Damage

Inflammatory and Hematologic Liver and Platelet (HALP) Scores in Hypothermia-Treated Hypoxic–Ischemic Encephalopathy (HIE)

Identification of Novel Biomarkers for Neonatal Hypoxic-Ischemic Encephalopathy Using Itraq

Changes of Serum Myelin Base Protein, Neuron Specific Enolase and Coronal-Ct Manifestions and Its Clinical Significance in Neonate Hypoxic Ischemic Encephalopathy

Clinical Significance of serum S-100β determination in neonates with hypoxic-ischemic encephalopathy

The Enhanced Ability of Peripheral Mononuclear Cells Differentiating into Neural Cells in Term Infants with Good Improvement Suffering from Severe Hypoxic Ischemic Encephalopathy

The Concentration of Neuropeptide Y in Plama of Neonates with Hypoxic-Ischemic Encephalopathy

Identifying Early Diagnostic Biomarkers Associated with Neonatal Hypoxic-Ischemic Encephalopathy

Early intervention and the prognosis of the neonates with hypoxic ischemic encephalopathy

Detection and analysis of myocardial enzymes and cTnI levels in neonates with hypoxic ischemic encephalopathy of different severity

Meta-analysis of Hypoxic-Ischemic Encephalopathy on Myelin Basic Protein levels

Plasmatic profiles of cytokines/chemokines, glial fibrillary acidic protein (GFAP) and MRI brain damage in neonates with hypoxic ischemic encephalopathy (HIE)

A clinical study on internal milieu disorder in newborn infants suffered with hypoxic ischemic encephalopathy